These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2894943

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)].
    Smolarz A, Roesch E, Lenz H, Neubert P, Abshagen U.
    Z Kardiol; 1984 Feb; 73(2):113-9. PubMed ID: 6719984
    [Abstract] [Full Text] [Related]

  • 43. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
    Geary RS, Leeds JM, Fitchett J, Burckin T, Truong L, Spainhour C, Creek M, Levin AA.
    Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
    [Abstract] [Full Text] [Related]

  • 44. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A, van Groeningen CJ, Kraal I, Gall H, Peters GJ, Lankelma J, Pinedo HM.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [Abstract] [Full Text] [Related]

  • 45. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [Abstract] [Full Text] [Related]

  • 46. Utilization of antidrug antibody fragments for the optimization of intraperitoneal drug therapy: studies using digoxin as a model drug.
    Balthasar J, Fung HL.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):734-9. PubMed ID: 8113985
    [Abstract] [Full Text] [Related]

  • 47. NTP technical report on the toxicity studies of methacrylonitrile (CAS No. 126-98-7). Administered by gavage to F344/N rats and B6C3F1 mice.
    Ghanayem BI.
    Toxic Rep Ser; 2000 May; (47):1-56, A1-E6. PubMed ID: 11803706
    [Abstract] [Full Text] [Related]

  • 48. [Immunopharmacologic treatment of 9 digitalis poisonings in children with sheep antidigoxin Fab].
    Smolarz A, Abshagen U.
    Monatsschr Kinderheilkd; 1985 Sep; 133(9):682-7. PubMed ID: 4058431
    [Abstract] [Full Text] [Related]

  • 49. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning.
    Lapostolle F, Borron SW, Verdier C, Taboulet P, Guerrier G, Adnet F, Clemessy JL, Bismuth C, Baud FJ.
    Crit Care Med; 2008 Nov; 36(11):3014-8. PubMed ID: 18824911
    [Abstract] [Full Text] [Related]

  • 50. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 51. Redistribution and enhanced urinary excretion of 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) in rats using HCB-specific IgG and Fab fragments.
    Keyler DE, Goon DJ, Shelver WL, Ross CA, Nagasawa HT, St Peter JV, Pentel PR.
    Biochem Pharmacol; 1994 Aug 17; 48(4):767-73. PubMed ID: 8080450
    [Abstract] [Full Text] [Related]

  • 52. Inverse targeting of peritoneal tumors: selective alteration of the disposition of methotrexate through the use of anti-methotrexate antibodies and antibody fragments.
    Balthasar JP, Fung HL.
    J Pharm Sci; 1996 Oct 17; 85(10):1035-43. PubMed ID: 8897267
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin.
    Nguyen A, Reyes AE, Zhang M, McDonald P, Wong WL, Damico LA, Dennis MS.
    Protein Eng Des Sel; 2006 Jul 17; 19(7):291-7. PubMed ID: 16621915
    [Abstract] [Full Text] [Related]

  • 55. Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat.
    Hong G, Bazin-Redureau MI, Scherrmann JM.
    J Pharm Sci; 1999 Jan 17; 88(1):147-53. PubMed ID: 9874717
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Contrasting rates of reversal of digoxin toxicity by digoxin-specific IgG and Fab fragments.
    Lloyd BL, Smith TW.
    Circulation; 1978 Aug 17; 58(2):280-3. PubMed ID: 668076
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.